Stryker Corporation (0R2S.L)
USD 327.13
(-6.4%)
USD 327.13
(-6.4%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.31 Billion USD | 5.19% |
| 2022 | 20.26 Billion USD | 2.6% |
| 2021 | 19.75 Billion USD | -7.02% |
| 2020 | 21.24 Billion USD | 22.38% |
| 2019 | 17.36 Billion USD | 12.01% |
| 2018 | 15.49 Billion USD | 27.16% |
| 2017 | 12.18 Billion USD | 11.98% |
| 2016 | 10.88 Billion USD | 40.71% |
| 2015 | 7.73 Billion USD | -15.15% |
| 2014 | 9.11 Billion USD | 36.16% |
| 2013 | 6.69 Billion USD | 37.49% |
| 2012 | 4.87 Billion USD | 3.13% |
| 2011 | 4.72 Billion USD | 26.88% |
| 2010 | 3.72 Billion USD | 50.29% |
| 2009 | 2.47 Billion USD | 12.73% |
| 2008 | 2.19 Billion USD | 11.19% |
| 2007 | 1.97 Billion USD | 17.39% |
| 2006 | 1.68 Billion USD | -0.56% |
| 2005 | 1.69 Billion USD | 27.07% |
| 2004 | 1.33 Billion USD | 32.61% |
| 2003 | 1 Billion USD | -23.76% |
| 2002 | 1.31 Billion USD | -3.66% |
| 2001 | 1.36 Billion USD | -13.23% |
| 2000 | 1.57 Billion USD | -17.45% |
| 1999 | 1.9 Billion USD | -13.9% |
| 1998 | 2.21 Billion USD | 558.67% |
| 1997 | 336.6 Million USD | -10.76% |
| 1996 | 377.2 Million USD | 27.6% |
| 1995 | 295.6 Million USD | -4.55% |
| 1994 | 309.7 Million USD | 86.79% |
| 1993 | 165.8 Million USD | 53.52% |
| 1992 | 108 Million USD | 19.47% |
| 1991 | 90.4 Million USD | 46.75% |
| 1990 | 61.6 Million USD | 52.85% |
| 1989 | 40.3 Million USD | 19.23% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 23.68 Billion USD | 22.28% |
| 2024 Q2 | 19.36 Billion USD | -4.26% |
| 2024 Q1 | 20.23 Billion USD | -5.11% |
| 2023 Q4 | 21.31 Billion USD | 5.87% |
| 2023 FY | 21.31 Billion USD | 5.19% |
| 2023 Q1 | 19.93 Billion USD | -1.64% |
| 2023 Q2 | 20.04 Billion USD | 0.57% |
| 2023 Q3 | 20.13 Billion USD | 0.44% |
| 2022 Q4 | 20.26 Billion USD | 3.83% |
| 2022 FY | 20.26 Billion USD | 2.6% |
| 2022 Q2 | 20.35 Billion USD | -3.48% |
| 2022 Q1 | 21.09 Billion USD | 6.77% |
| 2022 Q3 | 19.52 Billion USD | -4.12% |
| 2021 Q3 | 19.96 Billion USD | 0.45% |
| 2021 Q4 | 19.75 Billion USD | -1.07% |
| 2021 Q1 | 19.95 Billion USD | -6.09% |
| 2021 FY | 19.75 Billion USD | -7.02% |
| 2021 Q2 | 19.87 Billion USD | -0.38% |
| 2020 FY | 21.24 Billion USD | 22.38% |
| 2020 Q1 | 16.32 Billion USD | -5.96% |
| 2020 Q2 | 18.72 Billion USD | 14.73% |
| 2020 Q3 | 19.3 Billion USD | 3.05% |
| 2020 Q4 | 21.24 Billion USD | 10.08% |
| 2019 FY | 17.36 Billion USD | 12.01% |
| 2019 Q4 | 17.36 Billion USD | 21.03% |
| 2019 Q2 | 14.41 Billion USD | 1.17% |
| 2019 Q3 | 14.34 Billion USD | -0.46% |
| 2019 Q1 | 14.24 Billion USD | -8.1% |
| 2018 Q2 | 12.11 Billion USD | -6.2% |
| 2018 FY | 15.49 Billion USD | 27.16% |
| 2018 Q4 | 15.49 Billion USD | 26.79% |
| 2018 Q1 | 12.91 Billion USD | 5.92% |
| 2018 Q3 | 12.22 Billion USD | 0.94% |
| 2017 Q4 | 12.18 Billion USD | 10.21% |
| 2017 FY | 12.18 Billion USD | 11.98% |
| 2017 Q3 | 11.06 Billion USD | -1.75% |
| 2017 Q2 | 11.25 Billion USD | 4.11% |
| 2017 Q1 | 10.81 Billion USD | -0.66% |
| 2016 FY | 10.88 Billion USD | 40.71% |
| 2016 Q2 | 11.42 Billion USD | 5.17% |
| 2016 Q4 | 10.88 Billion USD | 0.28% |
| 2016 Q3 | 10.85 Billion USD | -4.96% |
| 2016 Q1 | 10.86 Billion USD | 40.38% |
| 2015 Q3 | 7.43 Billion USD | -10.6% |
| 2015 Q2 | 8.31 Billion USD | 0.67% |
| 2015 Q1 | 8.25 Billion USD | -9.41% |
| 2015 Q4 | 7.73 Billion USD | 4.08% |
| 2015 FY | 7.73 Billion USD | -15.15% |
| 2014 Q2 | 8.11 Billion USD | 14.39% |
| 2014 Q3 | 8.89 Billion USD | 9.54% |
| 2014 Q4 | 9.11 Billion USD | 2.54% |
| 2014 FY | 9.11 Billion USD | 36.16% |
| 2014 Q1 | 7.09 Billion USD | 5.97% |
| 2013 Q3 | 6.14 Billion USD | 6.35% |
| 2013 Q1 | 5.63 Billion USD | 15.67% |
| 2013 FY | 6.69 Billion USD | 37.49% |
| 2013 Q4 | 6.69 Billion USD | 8.95% |
| 2013 Q2 | 5.77 Billion USD | 2.59% |
| 2012 FY | 4.87 Billion USD | 3.13% |
| 2012 Q3 | 4.41 Billion USD | 2.46% |
| 2012 Q2 | 4.31 Billion USD | -2.86% |
| 2012 Q1 | 4.43 Billion USD | -6.04% |
| 2012 Q4 | 4.87 Billion USD | 10.28% |
| 2011 Q1 | 3.77 Billion USD | 1.53% |
| 2011 Q4 | 4.72 Billion USD | 4.33% |
| 2011 Q2 | 3.81 Billion USD | 1.05% |
| 2011 Q3 | 4.52 Billion USD | 18.53% |
| 2011 FY | 4.72 Billion USD | 26.88% |
| 2010 Q1 | 3.42 Billion USD | 38.42% |
| 2010 FY | 3.72 Billion USD | 50.29% |
| 2010 Q4 | 3.72 Billion USD | 7.37% |
| 2010 Q3 | 3.46 Billion USD | 4.56% |
| 2010 Q2 | 3.31 Billion USD | -3.3% |
| 2009 Q3 | 2.01 Billion USD | 8.16% |
| 2009 Q1 | 1.96 Billion USD | -10.77% |
| 2009 Q2 | 1.86 Billion USD | -4.8% |
| 2009 Q4 | 2.47 Billion USD | 22.69% |
| 2009 FY | 2.47 Billion USD | 12.73% |
| 2008 Q1 | 1.82 Billion USD | -7.81% |
| 2008 FY | 2.19 Billion USD | 11.19% |
| 2008 Q4 | 2.19 Billion USD | 20.07% |
| 2008 Q3 | 1.82 Billion USD | 1.29% |
| 2008 Q2 | 1.8 Billion USD | -0.83% |
| 2007 Q1 | 1.58 Billion USD | -5.59% |
| 2007 FY | 1.97 Billion USD | 17.39% |
| 2007 Q3 | 1.69 Billion USD | 4.87% |
| 2007 Q4 | 1.97 Billion USD | 16.38% |
| 2007 Q2 | 1.61 Billion USD | 1.88% |
| 2006 Q3 | 1.4 Billion USD | 5.13% |
| 2006 FY | 1.68 Billion USD | -0.56% |
| 2006 Q4 | 1.68 Billion USD | 19.47% |
| 2006 Q1 | 1.5 Billion USD | -11.03% |
| 2006 Q2 | 1.33 Billion USD | -11.01% |
| 2005 Q2 | 1.17 Billion USD | 0.57% |
| 2005 FY | 1.69 Billion USD | 27.07% |
| 2005 Q3 | 1.28 Billion USD | 8.83% |
| 2005 Q4 | 1.69 Billion USD | 31.89% |
| 2005 Q1 | 1.17 Billion USD | -11.98% |
| 2004 FY | 1.33 Billion USD | 32.61% |
| 2004 Q2 | 1 Billion USD | 6.7% |
| 2004 Q3 | 1.07 Billion USD | 6.94% |
| 2004 Q4 | 1.33 Billion USD | 23.67% |
| 2004 Q1 | 943.8 Million USD | -6.02% |
| 2003 FY | 1 Billion USD | -23.76% |
| 2003 Q3 | 1.02 Billion USD | -13.55% |
| 2003 Q2 | 1.18 Billion USD | -6.38% |
| 2003 Q1 | 1.26 Billion USD | -3.72% |
| 2003 Q4 | 1 Billion USD | -2.16% |
| 2002 Q4 | 1.31 Billion USD | -2.01% |
| 2002 Q2 | 1.27 Billion USD | -2.61% |
| 2002 Q1 | 1.31 Billion USD | -3.91% |
| 2002 FY | 1.31 Billion USD | -3.66% |
| 2002 Q3 | 1.34 Billion USD | 5.05% |
| 2001 Q4 | 1.36 Billion USD | -0.98% |
| 2001 Q3 | 1.38 Billion USD | -4.54% |
| 2001 Q1 | 1.51 Billion USD | -3.68% |
| 2001 FY | 1.36 Billion USD | -13.23% |
| 2001 Q2 | 1.44 Billion USD | -4.69% |
| 2000 Q4 | 1.57 Billion USD | -9.76% |
| 2000 Q3 | 1.74 Billion USD | -4.72% |
| 2000 Q2 | 1.83 Billion USD | -1.45% |
| 2000 Q1 | 1.86 Billion USD | -2.57% |
| 2000 FY | 1.57 Billion USD | -17.45% |
| 1999 Q1 | 2.17 Billion USD | -1.97% |
| 1999 FY | 1.9 Billion USD | -13.9% |
| 1999 Q2 | 2.07 Billion USD | -4.62% |
| 1999 Q4 | 1.9 Billion USD | -8.07% |
| 1999 Q3 | 2.07 Billion USD | 0.18% |
| 1998 Q4 | 2.21 Billion USD | 600.06% |
| 1998 Q2 | 303.1 Million USD | -3.9% |
| 1998 Q1 | 315.4 Million USD | -6.3% |
| 1998 Q3 | 316.7 Million USD | 4.49% |
| 1998 FY | 2.21 Billion USD | 558.67% |
| 1997 Q1 | 319.1 Million USD | -15.4% |
| 1997 FY | 336.6 Million USD | -10.76% |
| 1997 Q4 | 336.6 Million USD | 4.08% |
| 1997 Q3 | 323.4 Million USD | -0.03% |
| 1997 Q2 | 323.5 Million USD | 1.38% |
| 1996 Q2 | 281 Million USD | -4.19% |
| 1996 Q1 | 293.3 Million USD | -0.78% |
| 1996 Q3 | 301.8 Million USD | 7.4% |
| 1996 Q4 | 377.2 Million USD | 24.98% |
| 1996 FY | 377.2 Million USD | 27.6% |
| 1995 Q3 | 287.8 Million USD | -9.07% |
| 1995 FY | 295.6 Million USD | -4.55% |
| 1995 Q2 | 316.5 Million USD | 2.59% |
| 1995 Q1 | 308.5 Million USD | -0.39% |
| 1995 Q4 | 295.6 Million USD | 2.71% |
| 1994 FY | 309.7 Million USD | 86.79% |
| 1994 Q1 | 160.4 Million USD | -3.26% |
| 1994 Q2 | 166.6 Million USD | 3.87% |
| 1994 Q3 | 291.5 Million USD | 74.97% |
| 1994 Q4 | 309.7 Million USD | 6.24% |
| 1993 Q3 | 144.1 Million USD | 34.17% |
| 1993 Q4 | 165.8 Million USD | 15.06% |
| 1993 Q2 | 107.4 Million USD | 3.57% |
| 1993 Q1 | 103.7 Million USD | -3.98% |
| 1993 FY | 165.8 Million USD | 53.52% |
| 1992 Q2 | 79.5 Million USD | 3.79% |
| 1992 Q4 | 108 Million USD | 28.42% |
| 1992 Q3 | 84.1 Million USD | 5.79% |
| 1992 Q1 | 76.6 Million USD | -15.27% |
| 1992 FY | 108 Million USD | 19.47% |
| 1991 Q3 | 73.3 Million USD | 20.16% |
| 1991 Q4 | 90.4 Million USD | 23.33% |
| 1991 Q2 | 61 Million USD | -4.84% |
| 1991 FY | 90.4 Million USD | 46.75% |
| 1991 Q1 | 64.1 Million USD | 4.06% |
| 1990 Q1 | 42.9 Million USD | 6.45% |
| 1990 FY | 61.6 Million USD | 52.85% |
| 1990 Q2 | 42.5 Million USD | -0.93% |
| 1990 Q4 | 61.6 Million USD | 15.14% |
| 1990 Q3 | 53.5 Million USD | 25.88% |
| 1989 Q3 | 36.4 Million USD | 4.6% |
| 1989 Q2 | 34.8 Million USD | 0.0% |
| 1989 Q4 | 40.3 Million USD | 10.71% |
| 1989 FY | 40.3 Million USD | 19.23% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -17719.887% |
| Accuray Incorporated | 423.54 Million USD | -4933.491% |
| Align Technology, Inc. | 2.45 Billion USD | -768.962% |
| Elevance Health Inc. | 69.52 Billion USD | 69.335% |
| AxoGen, Inc. | 101.16 Million USD | -20974.119% |
| Boston Scientific Corporation | 15.6 Billion USD | -36.608% |
| CVS Health Corporation | 173.09 Billion USD | 87.683% |
| Cardinal Health, Inc. | 48.33 Billion USD | 55.891% |
| Centene Corporation | 58.68 Billion USD | 63.672% |
| DaVita Inc. | 14.87 Billion USD | -43.31% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 61.344% |
| Hologic, Inc. | 4.02 Billion USD | -429.533% |
| Humana Inc. | 30.74 Billion USD | 30.663% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -1100.803% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -141.313% |
| Masimo Corporation | 1.67 Billion USD | -1171.486% |
| McKesson Corporation | 69.04 Billion USD | 69.122% |
| Patterson Companies, Inc. | 1.89 Billion USD | -1025.013% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -180.366% |
| ResMed Inc. | 2 Billion USD | -961.518% |
| Henry Schein, Inc. | 5.42 Billion USD | -293.339% |
| Teladoc Health, Inc. | 2.06 Billion USD | -931.75% |
| Universal Health Services, Inc. | 8.15 Billion USD | -161.424% |
| Veeva Systems Inc. | 1.26 Billion USD | -1583.838% |
| Baxter International Inc. | 19.8 Billion USD | -7.628% |
| Becton, Dickinson and Company | 26.98 Billion USD | 20.994% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -942.902% |
| Danaher Corporation | 30.99 Billion USD | 31.225% |
| Medtronic plc | 39.56 Billion USD | 46.111% |